Literature DB >> 23070861

Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.

J Jahnel, H Lackner, F Reiterer, B Urlesberger, C Urban.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23070861     DOI： 10.1055/s-0032-1323823

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN： 0300-8630            Impact factor:   1.349


× No keyword cloud information.
  8 in total

Review 1.  Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.

Authors:  Irene Schmid; Anne K Klenk; Monika Sparber-Sauer; Ewa Koscielniak; Rebecca Maxwell; Beate Häberle
Journal:  World J Pediatr       Date:  2018-07-27       Impact factor: 2.764

2.  Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series.

Authors:  Anna Karastaneva; Paolo Gasparella; Sebastian Tschauner; Roman Crazzolara; Gabriele Kropshofer; Manfred Modl; Andreas Pfleger; Ante Burmas; Mirjam Pocivalnik; Raphael Ulreich; Werner Zenz; Wolfgang Schwinger; Besiana P Beqo; Christian Urban; Emir Q Haxhija; Herwig Lackner; Martin Benesch
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

3.  Sirolimus for the treatment of children with various complicated vascular anomalies.

Authors:  Herwig Lackner; Anna Karastaneva; Wolfgang Schwinger; Martin Benesch; Petra Sovinz; Markus Seidel; Daniela Sperl; Sofia Lanz; Emir Haxhija; Friedrich Reiterer; Erich Sorantin; Christian E Urban
Journal:  Eur J Pediatr       Date:  2015-06-04       Impact factor: 3.183

4.  A rare case of kaposiform hemangioendothelioma presenting as intussusception in a 4-month-old child without Kasabach-Merrit syndrome: A case report.

Authors:  Jujju Jacob Kurian; Ravi Kishore; Tarun Jacob John; Harshad Parmer
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10

5.  Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon.

Authors:  Alaa M Alaqeel; Nuha A Alfurayh; Alanoud A Alhedyani; Saad M Alajlan
Journal:  JAAD Case Rep       Date:  2016-12-05

6.  Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature.

Authors:  Matteo Chinello; Daniela Di Carlo; Francesca Olivieri; Rita Balter; Massimiliano De Bortoli; Virginia Vitale; Ada Zaccaron; Elisa Bonetti; Alice Parisi; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

7.  Initial dose recommendation for sirolimus in paediatric kaposiform haemangioendothelioma patients based on population pharmacokinetics and pharmacogenomics.

Authors:  Xiao Chen; Dong-Dong Wang; Hong Xu; Zhi-Ping Li
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

8.  Bifocal Tibial Kaposiform Hemangioendothelioma Responsive to Vincristine Therapy: A Case Report.

Authors:  Isam K Bsisu; Malik M Alkharabsheh; Belal B Al-Zu'bi; Ghadeer Almuhaisen; Abdullah S Awidi; Omar Q Samarah
Journal:  Am J Case Rep       Date:  2019-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.